Manufactuing process of 2.75 liters army liposome formulation 55, for the walter reed army institute of research.

Ended Definitive Contract Awarded Last action

Contract number
HT942524C0064
Awardee
Awarding agency
Obligated
$250,654

Award facts

Opportunity
Contract value 100% obligated
$250,654.04 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20910, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · Manufacturing of 2.75 liters of army liposome formulation (ALF) for walter reed army institute of research -$268,017
Original award $518,671

About this award

The Defense Health Agency awarded a $250,654.04 definitive contract to Avanti Polar Lipids, LLC for manufacturing 2.75 liters of Army Liposome Formulation 55 (ALF55) for the Walter Reed Army Institute of Research on July 15, 2024, under firm fixed price.

Place of performance is Silver Spring, MD. The originating solicitation, posted March 15, 2024, specified Good Manufacturing Practices manufacture of ALF55 drug substance containing 55 mol% cholesterol, with defined molar ratios of lipid constituents and analytical test methods. The ultimate completion date is January 1, 2025.

Quick answers

Who was awarded contract HT942524C0064?

HT942524C0064 was awarded to Avanti Polar Lipids, LLC by Defense Health Agency (Department of Defense) on July 15, 2024.

How much is contract HT942524C0064 worth?

The government has obligated $250,654 on HT942524C0064.

Was contract HT942524C0064 competed?

The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award